HK1214180A1 - 吡唑並噠嗪以及用於治療視網膜變性疾病和與厄舍綜合征綜合征相關的聽力喪失的方法 - Google Patents

吡唑並噠嗪以及用於治療視網膜變性疾病和與厄舍綜合征綜合征相關的聽力喪失的方法

Info

Publication number
HK1214180A1
HK1214180A1 HK16102422.6A HK16102422A HK1214180A1 HK 1214180 A1 HK1214180 A1 HK 1214180A1 HK 16102422 A HK16102422 A HK 16102422A HK 1214180 A1 HK1214180 A1 HK 1214180A1
Authority
HK
Hong Kong
Prior art keywords
pyrazolopyridazines
methods
hearing loss
degenerative diseases
loss associated
Prior art date
Application number
HK16102422.6A
Other languages
English (en)
Inventor
Roland Werner Burli
William Rameshchandra Krishna Esmieu
Christopher James Lock
Karine Fabienne Malagu
Andrew Pate Owens
William Edward Harte
Original Assignee
Usher Iii Initiative Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Usher Iii Initiative Inc filed Critical Usher Iii Initiative Inc
Publication of HK1214180A1 publication Critical patent/HK1214180A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
HK16102422.6A 2012-10-25 2016-03-02 吡唑並噠嗪以及用於治療視網膜變性疾病和與厄舍綜合征綜合征相關的聽力喪失的方法 HK1214180A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261718611P 2012-10-25 2012-10-25
US201361775402P 2013-03-08 2013-03-08
PCT/US2013/066939 WO2014066836A1 (en) 2012-10-25 2013-10-25 Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome

Publications (1)

Publication Number Publication Date
HK1214180A1 true HK1214180A1 (zh) 2016-07-22

Family

ID=50545356

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16102422.6A HK1214180A1 (zh) 2012-10-25 2016-03-02 吡唑並噠嗪以及用於治療視網膜變性疾病和與厄舍綜合征綜合征相關的聽力喪失的方法

Country Status (11)

Country Link
EP (1) EP2911671B1 (zh)
JP (1) JP6291502B2 (zh)
AU (1) AU2013334139B2 (zh)
CA (1) CA2889494C (zh)
ES (1) ES2687854T3 (zh)
HK (1) HK1214180A1 (zh)
HU (1) HUE039970T2 (zh)
IL (1) IL238288B (zh)
PL (1) PL2911671T3 (zh)
WO (1) WO2014066836A1 (zh)
ZA (1) ZA201502655B (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2701510B1 (en) 2011-04-25 2017-02-15 Usher III Initiative Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
US9227976B2 (en) 2012-10-25 2016-01-05 Usher Iii Initiative, Inc. Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
PL2912038T3 (pl) * 2012-10-25 2019-02-28 Usher Iii Initiative, Inc. Pirazolopirydazyny oraz sposoby leczenia zwyrodnieniowych chorób siatkówki i utraty słuchu związanych z zespołem ushera
WO2017045955A1 (en) * 2015-09-14 2017-03-23 Basf Se Heterobicyclic compounds
CN112135815A (zh) 2018-03-27 2020-12-25 Ptc医疗公司 用于治疗亨廷顿氏病的化合物
AU2019294478B2 (en) 2018-06-27 2023-03-23 Ptc Therapeutics, Inc. Heterocyclic and heteroaryl compounds for treating Huntington's disease
WO2020161209A1 (en) 2019-02-06 2020-08-13 Syngenta Crop Protection Ag Herbicidal fused pyridazine compounds
WO2020161208A1 (en) 2019-02-06 2020-08-13 Syngenta Crop Protection Ag Herbicidal fused pyridazine compounds
WO2023139091A1 (en) * 2022-01-19 2023-07-27 INSERM (Institut National de la Santé et de la Recherche Médicale) Geralexin and uses thereof for the treatment of retinal degenerative diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0206723D0 (en) * 2002-03-21 2002-05-01 Glaxo Group Ltd Novel compounds
WO2007075911A2 (en) * 2005-12-22 2007-07-05 Yale University Inhibition of glycogen synthase kinase and methods of treating autoimmune or immune inflammatory disease
US20100331297A1 (en) * 2007-11-07 2010-12-30 Foldrx Pharmaceuticals, Inc. Modulation of protein trafficking
EP2701510B1 (en) * 2011-04-25 2017-02-15 Usher III Initiative Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome
PL2912038T3 (pl) * 2012-10-25 2019-02-28 Usher Iii Initiative, Inc. Pirazolopirydazyny oraz sposoby leczenia zwyrodnieniowych chorób siatkówki i utraty słuchu związanych z zespołem ushera

Also Published As

Publication number Publication date
IL238288A0 (en) 2015-06-30
HUE039970T2 (hu) 2019-02-28
JP2015535257A (ja) 2015-12-10
AU2013334139B2 (en) 2017-08-03
EP2911671A1 (en) 2015-09-02
PL2911671T3 (pl) 2018-11-30
CA2889494C (en) 2018-12-18
IL238288B (en) 2018-04-30
ZA201502655B (en) 2017-11-29
CA2889494A1 (en) 2014-05-01
JP6291502B2 (ja) 2018-03-14
EP2911671B1 (en) 2018-06-27
WO2014066836A1 (en) 2014-05-01
AU2013334139A1 (en) 2015-04-30
ES2687854T3 (es) 2018-10-29
EP2911671A4 (en) 2016-09-14

Similar Documents

Publication Publication Date Title
ZA201507790B (en) Enhanced adoptive cell therapy
GB2500915B (en) Arrangement and method
HK1214180A1 (zh) 吡唑並噠嗪以及用於治療視網膜變性疾病和與厄舍綜合征綜合征相關的聽力喪失的方法
HK1206666A1 (zh) 光療裝置和方法
SG10201609812SA (en) System and process for retina phototherapy
EP2820527A4 (en) DEVICE AND CORRESPONDING METHODS
TWI561481B (en) Glass manufacturing apparatus and methods
EP2904647A4 (en) DEVICE AND CORRESPONDING METHODS
ZA201307961B (en) Pyrazolopyridazines and methods for treating retinal-degenarative diseases and hearing loss associated with usher syndrome
EP2828615A4 (en) LASER GRAMMING SYSTEM AND METHOD
HK1211875A1 (zh) 治療聽力損失的方法
EP2850678A4 (en) APPARATUS AND ASSOCIATED METHODS
GB201217070D0 (en) Airflow modification patch and method
GB201310158D0 (en) Medico-surgical assemblies and means
HK1214263A1 (zh) 吡唑並噠嗪以及用於治療視網膜變性疾病和與厄舍綜合征綜合征相關的聽力喪失的方法
EP2910675A4 (en) MODIFIED FIBER AND METHOD FOR MANUFACTURING THE SAME
GB2504303B (en) Earphones and earplugs
GB201213782D0 (en) Process and dressing
EP2928460A4 (en) METHODS FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY SKIN DISEASES
EP2809285A4 (en) HYPERBARE CHAMBER SYSTEM AND ASSOCIATED METHODS
GB201213778D0 (en) Process and dressng
GB201221092D0 (en) Assemblies and methods
GB2519994B (en) Assemblies and methods
GB201211961D0 (en) Methods and groups
GB201208845D0 (en) Methods and groups